Noncommunicable Disease Risk Factors in the Americas: Considerations on the Strengthening of Regulatory Capacity. REGULA Technical Reference Document
MetadatosMostrar el registro completo del ítem
[Executive Summary]. This document, prepared under the the Organization’s innovative initiative “Strengthening Regulatory Capacity in the Region of the Americas for NCD Risk Factors” (REGULA), provides an overview of the status of key noncommunicable disease (NCD) risk factors in the Americas and fulfillment of international agreements that support action by Ministries of Health to protect populations from the associated risks factors. It reviews the current regulatory situation in the Region, resents the key conceptual and operational elements of effective regulation, and proposes lines of action for technical cooperation to strengthen regulatory capacity for NCDs in the Americas. Its focus is on regulation, an approach that has been clearly recognized as an essential public health function and one in which capacity lags behind other fields of public health action. Strengthening regulatory capacity and action is by no means the only approach to reducing NCD risk factors, but it is an indispensable component of the suite of actions needed to prevent and control noncommunicable disease in the Region. Ten of the 15 “very cost-effective” interventions (also called “best-buys”) cited in the WHO Global Action Plan on NCDs and the WHO Global Status Report on NCDs (2014) involve the effective use of law or regulation. It has been estimated that these population-based interventions can be provided in low- and middle-income countries at a cost of US$ 0.20 per capita and in upper middle-income countries for US$ 0.50 per capita (WHO, 2011c).
Factores de riesgo de las enfermedades no transmisibles en la Región de las Américas: Consideraciones para fortalecer la capacidad regulatoria. Documento técnico de referencia REGULAFatores de risco para doenças não transmissíveis nas Américas: Considerações sobre o fortalecimento da capacidade regulatória. Documento de referência técnica REGULA
Categoría del Plan Estratégico 2014-2019 de la OPS
Mostrando ítems relacionados por Título, autor o materia.
Strengthening of regulatory systems for medicines in the Americas Etienne, Carissa F.; Califf, Robert (2016-05)Health regulation is regarded as one of public health’s basic functions. Effective regulation of medicines promotes and protects the public’s health by guaranteeing medicines quality, safety, and efficacy; promoting the ...
Plan of Action for the Elimination of Industrially Produced Trans-Fatty Acids 2020-2025 Pan American Health Organization; Noncommunicable Diseases and Mental Health (NMH) (Washington, D.C., PAHO, 2020-03-31)[Introduction]: Industrially produced trans-fatty acids (IP-TFA) are a significant and preventable contributing factor to the burden of cardiovascular disease, the leading cause of death in the Americas. June 2018 marks a ...
HEARTS in the Americas: Regulatory Pathway to the Exclusive Use of Validated Blood Pressure Measuring Devices Pan American Health Organization; Noncommunicable Diseases and Mental Health (NMH) (Washington, D.C., PAHO, 2021-12-15)Cardiovascular disease (CVD) is the leading cause of disease burden globally. According to the 2017 Global Burden of Disease estimates, there were 14 million new cases of CVD, 80 million people living with this condition, ...